A new business partnership of S&P Consultants, Inc. and Vedant Incorporated will now offer the highest levels of quality- and patient-safety assurance to both standard and customized applications built on the Cerner Millennium® platform. Both companies have particular expertise in the Cerner Millennium® environment, with S&P providing a broad range of consulting services and Vedant offering TestStream®, a comprehensive suite of software testing and validation solutions for systems of all levels of complexity and scale.
The partnership will enable S&P to utilize the Vedant testing tools to market, utilize and develop customized quality-governance configurations for Cerner Millennium® applications. In addition, Cerner users will now be able to validate both their standard and customized Cerner Millennium® database builds utilizing S&P configurations within Vedant’s Scenario Definition™ product.
“We are excited about this new collaboration with Vedant, especially when incorporating TestStream into our Cerner Millennium® implementations, version upgrades and Blood Bank validations,” commented Andrew Splitz, President and CEO of S&P Consultants. “We will be able to quickly and accurately provide complete database and application functionality validation, allowing our clinical staff to focus even more closely on client application design and clinical department workflow. Although standard Cerner Millennium® implementations require one to three version upgrades during the life cycle of the migration, the Vedant solutions will reduce the time and resources required for the project stop and new code validation cycle. With this partnership, unit, functional, system and integration testing can all be customized according to clients' specific settings and workflows. Our partnership allows clients to fully leverage Cerner Millennium’s extensive workflow customization capabilities, assuring the optimal patient experience."
Through use of Vedant's comprehensive quality-governance solutions for the testing phases of Cerner Millennium® projects, S&P will assure the highest levels of end-user experience and patient safety. The partnership also provides for customized TestStream-based Blood Bank validation configuration libraries, which dramatically reduce client resource burdens during validations. Similarly, S&P will now be able to validate the database, application functionality and client workflows, drastically cutting the time it takes to complete version upgrades from two to four months to only four to six weeks.
"S&P brings unrivaled understanding of the functionality of Cerner® applications, affording unique advantages in implementing these systems against individual client and patient needs," said Scott Almeda, CEO of Vedant. "Providing our mutual clients with the ability to customize their applications with S&P, while governing quality with TestStream, is a win-win for the end-user and patients alike.”
Beer consumption alters red blood cell lipid composition